本页面由Tiger Trade Technology Pte. Ltd.提供服务

Pasithea Therapeutics Corp.

0.7000
-0.0200-2.78%
盘后0.70000.00000.00%19:52 EDT
成交量:43.56万
成交额:30.57万
市值:1,745.79万
市盈率:-0.24
高:0.7369
开:0.7090
低:0.6900
收:0.7200
52周最高:3.79
52周最低:0.2810
股本:2,493.99万
流通股本:1,675.34万
量比:0.65
换手率:2.60%
股息:- -
股息率:- -
每股收益(TTM):-2.9100
每股收益(LYR):-2.9100
净资产收益率:-58.36%
总资产收益率:-27.35%
市净率:0.32
市盈率(LYR):-0.24

数据加载中...

2023/07/20

重要事件披露

Form 8-K - Current report
2023/06/08

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/06/01

SEC问询函

Form CORRESP - Correspondence
2023/05/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/17

SEC问询函

Form CORRESP - Correspondence
2023/04/04

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/30

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/30

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/10

重要事件披露

8-K - Current report
2023/02/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/24

重要事件披露

8-K - Current report
2023/01/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/10

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/14

重要事件披露

8-K - Current report
2022/12/14

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/11/14

SEC问询函

CORRESP [Cover] - Correspondence
2022/11/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/01

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/10/20

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/10/12

重要事件披露

8-K - Current report